Sanofi receives FDA approval for Tzield in paediatric diabetes
The decision is supported by one-year data from the PETITE-T1D Phase IV study evaluating Tzield in children.
Drug Development
MSD teams up with Google Cloud on agentic AI transformation
BioAegis and Prenosis partner for inflammatory disease therapies
Health Canada approves Biocon’s two denosumab biosimilars
Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy
Asahi Kasei acquires German company Aicuris
Beyond GLP-1Rs: emerging targets poised to gain share of obesity market
UCB to purchase Neurona and NRTX-1001 for $1.15bn
